futurehealth.com tirzepatide FDA Grants a New Indication for Obesity Management yourfuturhealth update! #ad #tirzepatide #glp1

When to discard Discard tirzepatide immediately if: The printed expiration date or beyond-use date has passed The solution is cloudy, discolored, or contains particles The vial has been at room temperature for more than 21 days (brand-name) or past your pharmacy's specified window (compounded) The medication has been frozen at any point The medication has been exposed to temperatures above 86 degrees Fahrenheit An opened vial has been punctured for more than 28 days You are unsure of the storage history The container shows any damage or leakage When in doubt, throw it out

Rare but reported issues include gallbladder disease and pancreatitis

Medication-related side effects are primarily gastrointestinal and are most pronounced during the early weeks of treatment and after each dose increase

The medication is administered once weekly via subcutaneous injection, with doses ranging from 2.5 mg to 15 mg

The male body image paradox The Kinsey survey found that 59% of GLP-1 users reported changes in their dating behaviors